Skip to main content
. 2020 Sep 4;11:4417. doi: 10.1038/s41467-020-18233-x

Fig. 2. Inhibition of SARS-CoV-2 replication in Vero cells by Boceprevir and GC376.

Fig. 2

a The inhibitory effect of Boceprevir and GC376 treatment on SARS-CoV-2 replication. Remdesivir was used as a positive control. b The relative concentration of viral RNA present in the supernatant at 72h post infection determined by Real-time quantitative PCR analysis after Boceprevir and GC376 treatment, unpaired t test for comparison of relative viral RNA copies incubated with inhibitor vs virus control (n = 3 independent replicates). p = 0.0036, 0.6474, 0.0003 for 8 μM Boceprevir, 0.32 μM GC376, and 0.8 μM Remdesivir, respectively (ns: not significant P > 0.05, **P < 0.01, ***P < 0.001). cf Virus-induced cytopathic effect in Vero cells after Boceprevir and GC376 treatment. Scale bar represents 100 μm. Error bars: mean ± S.D. of three independent replicates. Source data are provided as a source data file.